Editorial & Institutional Desk

Mangoceuticals (MGRX) Institutional & Peer Valuation Brief: MedTech & Digital Health vs. SENS, MODD, and DRIO

By the PubCo Insight Editorial Desk, edited by Brad Listermann  ·  November 20, 2026
MGRX
MGRX MANGOCEUTICALS, INC.
PubCo Insight Institutional & Sector Brief: Covering MANGOCEUTICALS, INC. (Nasdaq: MGRX) following its 2026-11-13 Form 8-K. Prepared for PubCo Insight’s verified vault of 22,361 Active Microcap Traders, Prop Desks & Family Offices.

1. Balance Sheet, SEC Filing & Operating Context (2026-11-13 Form 8-K)

MANGOCEUTICALS, INC. (Nasdaq: $MGRX, market capitalization ~$18.0M), led by Jacob Cohen, operates across commercial medical-device adoption, diagnostic scaling, and healthcare margin expansion. Primary SEC EDGAR XBRL records reflect capital-markets disclosure via its 2026-11-12 Form 1-A, anchoring investor diligence around balance-sheet runway and commercial execution.

MGRX price and volume
MGRX price and volume, last 90 days. Source: Yahoo Finance.

2. Institutional & Family Office Peer Comparison ($SENS, $MODD, and $DRIO)

Across our institutional and active small-cap allocator screens benchmarking $MGRX against $SENS, $MODD, and $DRIO, three factors stand out:

Free Public-Company AI & Investor Search Visibility Report

MANGOCEUTICALS, INC. ($MGRX) Investor Search & Diligence Audit

38 / 100
Visibility Score

Why This Costs $MGRX Buyers & Volume: Before retail traders, family offices, or microcap funds buy a single share of $MGRX, over 70% run a 30-second search across ChatGPT, Perplexity Finance, and TradingView. When prospective investors cannot find clean, current SEC figures or hit stale third-party data, they skip out, do not invest, and buy a peer instead. Here is what investors currently see when they search MANGOCEUTICALS, INC.:

Investor Search SurfaceScoreWhere Prospective Buyers Are Dropping Off
ChatGPT & OpenAI Search35/100Missing root /llms.txt manifest and structured IR schema; surfaces stale baseline summaries instead of recent $MGRX SEC filings.
Perplexity Finance & Citations42/100Pulls fragmented quote-scraper snippets instead of verified SEC EDGAR operating milestones and peer valuation context for $MGRX.
TradingView, FactSet & Sector Screens37/100$MGRX is omitted from AI discovery screens covering commercial medical-device adoption, diagnostic scaling, and healthcare margin expansion due to unindexed entity and FAQPage metadata.
Turnkey Cleanup & Investor Distribution Package for MANGOCEUTICALS, INC.: Pulse IR fixes how ChatGPT, Perplexity, TradingView, FactSet, Wikidata, and your IR page display $MGRX directly from your SEC filings (requiring zero hours from your team), and then distributes your verified story to our 22,361 active microcap traders and 158 family offices and funds tracking your sector. To claim this report and review our turnkey package with CEO Brad Listermann, visit pulseir.co or call 424-250-0042.

Primary sources (SEC EDGAR)

MGRX Primary SEC EDGAR Filings: https://www.sec.gov/edgar/browse/?CIK=0001938046
Compiled by the PubCo Insight Editorial & Institutional Desk from primary SEC EDGAR disclosures and market data. Published for informational and research purposes only, not investment advice or a buy/sell recommendation.
Investor relations · MGRX
Is this how AI describes MANGOCEUTICALS, INC.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for MGRX: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent MGRX, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
See all MGRX filings and data  ·  Uplist Radar  ·  Catalyst Radar  ·  Pulse IR Capital & Institutional Desk